Meet Gordon Mills, MD, PhD
OHSU announced that internationally renowned scientist Gordon B. Mills, MD, PhD, has been recruited to lead precision oncology for the Knight Cancer Institute. Here are a few interesting facts about him.
All Stories
6 things to know about childhood cancer
Overall, cancer in children is rare. But Joe, Ethan and Sophia battled the two most common types: brain tumors and leukemia. Here are six things to know about the pediatric cancers they faced: All brain tumors are cancer. All brain tumors are eventually fatal or disabling without treatment. Brain tumors are the 2nd most common […]
A new age of cancer research
The OHSU Knight Cancer Institute has launched the largest program of its kind in the world: the Center for Cancer Early Detection and Research (CEDAR). Early detection remains one of the largest unmet needs in cancer research — yet we know that when we find and treat cancer earlier, more people live. That’s easy to […]
Magazine: Onward, Fall 2016
From Idea to Impact. Notes from the front lines of the HIV crisis. Bench to bedside: How new treatments are born.
Engineering a new future in cancer care
OHSU Knight Cancer Institute Director Brian Druker, M.D., is famous for ignoring the conventional wisdom. He disregarded those who called his research “voodoo science” and his work resulted in GleevecTM – a landmark drug proven effective in 10 types of cancer. In selecting Sadik Esener, Ph.D., to lead the institute’s newly established Center for Early […]
